This bill was followed up on 12 February by a letter from members of the Select Committee arguing for specific sanctions against WuXi AppTec, a multinational biotech and medical devices company headquartered in Shanghai. The letter claims that the company has ties to the PLA and as such represents a threat to national security, a claim it strongly denies. A statement on its website states that "WuXi AppTec has a strong track record of upholding the highest intellectual property, data and privacy protection standards, as well as maintaining the trust of our customers." The company has in the past worked with Pfizer, AstraZeneca and GSK, amongst others.